Report Company Directory

NEUROBIOLOGICAL TECHNOLOGIES INC

NEUROBO PHARMACEUTICALS INC

• InsiderInsights Weekly Report: July 13, 2024 by InsiderInsights.com
• InsiderInsights.com Daily Ratings Report: July 10, 2024 by InsiderInsights.com
• InsiderInsights Weekly Report: July 6, 2024 by InsiderInsights.com
• InsiderInsights Weekly Report: June 29, 2024 by InsiderInsights.com
• InsiderInsights.com Daily Ratings Report: June 25, 2024 by InsiderInsights.com

Neurocrine Biosciences Inc.

• Fast Forward No. 762 by William Blair
• Weekly Prescription Sales Tracker: Neurology, Nephrology, GI, Cardiology by Wedbush
• US Pharmaceuticals "SMID-Biotech: Incomings, sentiment & Quant crowding..." by UBS AG
• HOLT SMID "Beyond the Giants: The Opportunity in Small and Mid-Cap" Smith by UBS AG
• Fast Forward No. 761 by William Blair
• Weekly Prescription Sales Tracker: Neurology, Nephrology, GI, Cardiology by Wedbush
• Fast Forward No. 760 by William Blair
• Weekly Prescription Sales Tracker: Neurology, Nephrology, GI, Cardiology by Wedbush
• Fast Forward No. 759 by William Blair
• Weekly Prescription Sales Tracker: Neurology, Nephrology, GI, Cardiology by Wedbush

NeuroDerm Ltd.

NEUROGENE INC

• Fast Forward No. 762 by William Blair
• Fast Forward No. 761 by William Blair
• Firing of Top FDA Cell and Gene Therapy Leaders Adds Uncertainty, but Prasad and Makary Commentary Remains Supportive by William Blair
• Fast Forward No. 760 by William Blair
• Fast Forward No. 759 by William Blair
• Today at 10 a.m. ET: Growth Stock Conference 2025 Recap Call by William Blair
• Fast Forward No. 758 by William Blair
• Growth Stock Conference 2025 Recap Call: June 6 at 10 a.m. ET by William Blair
• Elements of Competitor's Registrational Trial De-risks NGN-401 Pivotal Trial Design Ahead of Near-Term Update by William Blair
• ASCO 2025 Preview: Key Presentations and Posters, Our Relevant Conference Itinerary, and Events for Your Calendar by William Blair